dr n. med. Anna Sztafińska

Publickacje naukowe

• Stelmach I, Sztafińska A, Woicka-Kolejwa K, Jerzyńska J. Omalizumab in the prevention of anaphylaxis during immunotherapy: a case report. Advances in Dermatology and Allergology/Postȩpy Dermatologii i Alergologii. 2014;31(3):191-193.
• Jerzyńska J, Sztafińska A, Woicka-Kolejwa K, Stelmach I. Omalizumab as a new therapeutic approach for children with severe asthma. Advances in Dermatology and Allergology/Postȩpy Dermatologii i Alergologii. 2014;31(1):45-46.
• Stelmach I, Sztafińska A, Lechańska J, Balcerak J, Jerzyńska J. Exercise-induced urticaria and angioedema - case report. Pneumonol Alergol Pol. 2014;82(5):467-71.
• Sztafińska A, Jerzyńska J, Stelmach W, Woicka-Kolejwa K, Stelmach I. Quality of life in asthmatic children and their caregivers after two-year treatment with omalizumab - real-life study. Advances in Dermatology and Allergology. - przyjęty do druku, zostanie prawdopodobnie opublikowany w zeszycie 4/2017.
• Stelmach I, Zaczeniuk M, Sztafińska A, Majak P, Jerzyńska J, Kuklińska-Pijanka A, Stelmach W. Serum tryptase level and inflammatory markers in exhaled breath condensate of children with exercise-induced symptoms. Allergy Asthma Proc. 2016 Sep;37(5):84-92
• Olszowiec-Chlebna M, Sztafińska A, Stelmach I. Teenager suffered from idiopathic anaphylaxis and chronic spontaneous urticaria successfully treated with omalizumab – a case report. Pediatr Allergy Immunol Pulmonol. March 2016, 29(1): 53-55.
• Stelmach I, Sztafińska A, Jerzyńska J, Podlecka D, Majak P, Stelmach W. New insights into treatment of children with exercise-induced asthma symtpoms. Allergy Asthma Proc. November/December 2016, pp. 466-474(9).